Literature DB >> 22414916

Genetic support and diversity of acquired extended-spectrum β-lactamases in Gram-negative rods.

Laurent Poirel1, Rémy A Bonnin, Patrice Nordmann.   

Abstract

Genes encoding extended-spectrum β-lactamases (ESBLs) have been reported in a variety of Gram-negative species, mostly in Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter baumannii. They are either TEM- or SHV-derivatives, CTX-M-like enzymes and less frequently of the GES, PER, or VEB types. The mechanisms at the origin of their acquisition are diverse, and mostly are related to insertion sequences, transposons and class 1 integrons. This diversity of genetic vehicles at the origin of these mobilization/acquisition processes may explain spread of ESBLs worldwide.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22414916     DOI: 10.1016/j.meegid.2012.02.008

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  49 in total

1.  Rapid detection of extended-spectrum-β-lactamase-producing Enterobacteriaceae.

Authors:  Patrice Nordmann; Laurent Dortet; Laurent Poirel
Journal:  J Clin Microbiol       Date:  2012-07-03       Impact factor: 5.948

2.  IncH-type plasmid harboring bla CTX-M-15, bla DHA-1, and qnrB4 genes recovered from animal isolates.

Authors:  Andreas Schlüter; Patrice Nordmann; Rémy A Bonnin; Yves Millemann; Felix G Eikmeyer; Daniel Wibberg; Alfred Pühler; Laurent Poirel
Journal:  Antimicrob Agents Chemother       Date:  2014-04-21       Impact factor: 5.191

3.  Molecular characterization of ISCR1-mediated blaPER-1 in a non-O1, non-O139 Vibrio cholerae strain from China.

Authors:  Jun Wu; Lianyan Xie; Fangfang Zhang; Yuxing Ni; Jingyong Sun
Journal:  Antimicrob Agents Chemother       Date:  2015-04-13       Impact factor: 5.191

4.  High-Resolution Analysis by Whole-Genome Sequencing of an International Lineage (Sequence Type 111) of Pseudomonas aeruginosa Associated with Metallo-Carbapenemases in the United Kingdom.

Authors:  Jane F Turton; Laura Wright; Anthony Underwood; Adam A Witney; Yuen-Ting Chan; Ali Al-Shahib; Catherine Arnold; Michel Doumith; Bharat Patel; Timothy D Planche; Jonathan Green; Richard Holliman; Neil Woodford
Journal:  J Clin Microbiol       Date:  2015-06-03       Impact factor: 5.948

Review 5.  Molecular mechanisms of antibiotic resistance.

Authors:  Jessica M A Blair; Mark A Webber; Alison J Baylay; David O Ogbolu; Laura J V Piddock
Journal:  Nat Rev Microbiol       Date:  2014-12-01       Impact factor: 60.633

6.  Detection of GES-5 Carbapenemase in Klebsiella pneumoniae, a Newcomer in France.

Authors:  Rémy A Bonnin; Agnès B Jousset; Noémie Urvoy; Lauraine Gauthier; Linda Tlili; Elodie Creton; Garance Cotellon; Fabienne Arthur; Laurent Dortet; Thierry Naas
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

7.  Genetic and Biochemical Characterization of OXA-519, a Novel OXA-48-Like β-Lactamase.

Authors:  Laura Dabos; Pierre Bogaerts; Remy A Bonnin; Agustin Zavala; Pierre Sacré; Bogdan I Iorga; Daniel T Huang; Youri Glupczynski; Thierry Naas
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

8.  In vitro prediction of the evolution of GES-1 β-lactamase hydrolytic activity.

Authors:  Séverine Bontron; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2015-01-05       Impact factor: 5.191

9.  Comparative genomics of IncL/M-type plasmids: evolution by acquisition of resistance genes and insertion sequences.

Authors:  Rémy A Bonnin; Patrice Nordmann; Alessandra Carattoli; Laurent Poirel
Journal:  Antimicrob Agents Chemother       Date:  2012-10-31       Impact factor: 5.191

10.  Role of Pseudomonas aeruginosa AmpR on β-lactam and non-β-lactam transient cross-resistance upon pre-exposure to subinhibitory concentrations of antibiotics.

Authors:  Hansi Kumari; Deepak Balasubramanian; Diansy Zincke; Kalai Mathee
Journal:  J Med Microbiol       Date:  2014-01-25       Impact factor: 2.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.